GlassScriptPhysician profile
Amit Bahia
NPI 1326010190
$8,439.60
in general payments reported to CMS, 2019-2025
17 companies · $2,401 in 2025
The $2,401 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2021: $243 · 2022: $1,264 · 2023: $532 · 2024: $3,779 · 2025: $2,401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,056 · Food and Beverage: $2,656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,055.71 |
| Food and Beverage | $2,655.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,678.93 | 2019-2025 | Optis, Perclose Proglide, Dragonfly Opstar |
| Terumo Medical Corporation | $1,520.28 | 2025 | Glidewire |
| Medtronic, INC. | $1,288.27 | 2021-2024 | Hawkone |
| Edwards Lifesciences Corporation | $723.62 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inari Medical, INC. | $261.96 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Penumbra, INC. | $190.26 | 2023-2025 | Indigo System |
| Philips North America LLC | $183.84 | 2023-2024 | (9266) Elca |
| Abiomed | $139.36 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $94.25 | 2023 | Camzyos |
| Angiodynamics, INC. | $93.76 | 2022 | |
| Boston Scientific Corporation | $76.44 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $75.00 | 2021 | |
| Shockwave Medical, INC | $33.82 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $21.88 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.39 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18.39 | 2022-2025 | Lifevest |
| Cvrx, INC. | $18.15 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Bahia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.